Bioxytran, Inc.
BIXT
$0.1567
-$0.0054-3.33%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -25.55% | 39.38% | 17.32% | 22.30% | 14.89% |
| Total Depreciation and Amortization | 93.33% | 0.00% | -25.00% | -47.37% | 111.11% |
| Total Amortization of Deferred Charges | 2,391.20% | -16.67% | -- | -- | -- |
| Total Other Non-Cash Items | -425.86% | -21.50% | -85.24% | 309.44% | -159.50% |
| Change in Net Operating Assets | -73.88% | -30.75% | 87.07% | -76.30% | 127.78% |
| Cash from Operations | 46.03% | 155.41% | 27.91% | 18.36% | 72.97% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.97% | -727.27% | 81.67% | 9.09% | 48.03% |
| Cash from Investing | -32.97% | -727.27% | 81.67% | 9.09% | 48.03% |
| Total Debt Issued | -- | -- | -100.00% | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 1,375.00% | -91.11% | -88.47% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -9.92% | 45.56% | -88.47% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -239.15% | 505.71% | 121.74% | 70.30% | -254.42% |